CSIMarket Company Name, Ticker, Competitors, else..
 
Avantor Inc   (AVTR)
Other Ticker:  
 
 
Price: $24.7700 $-0.03 -0.121%
Day's High: $24.965 Week Perf: -1.43 %
Day's Low: $ 24.59 30 Day Perf: -6.42 %
Volume (M): 4,260 52 Wk High: $ 28.00
Volume (M$): $ 105,530 52 Wk Avg: $23.33
Open: $24.71 52 Wk Low: $16.63



 Market Capitalization (Millions $) 16,908
 Shares Outstanding (Millions) 683
 Employees -
 Revenues (TTM) (Millions $) 6,826
 Net Income (TTM) (Millions $) 360
 Cash Flow (TTM) (Millions $) 36
 Capital Exp. (TTM) (Millions $) 169

Avantor Inc
Avantor Inc is a global provider of products, services, and solutions to professionals in the life sciences and advanced technologies industries. The company offers a wide range of materials, laboratory equipment, chemicals, and consumables to support research and development, quality control, and production processes. Avantor operates in more than 30 countries and serves customers in pharmaceutical, biotechnology, healthcare, and semiconductor sectors, among others. They focus on delivering high-quality products, technical expertise, and customized solutions to help their customers advance their work and improve outcomes.


   Company Address: Radnor Corporate Center, Building One, Suite 200 Radnor 19087 PA
   Company Phone Number: 386-1700   Stock Exchange / Ticker: NYSE AVTR


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Avantor Inc

Avantor Inc Faces Tough First Quarter with Decline in Revenue and Profitability

Avantor Inc, a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, and applied materials industries, has experienced a decline in its financial performance for the January to March 2024 period. The company's net profit per share dropped by 50% to $0.09 compared to $0.18 in the previous year, while income decreased by 37.79% from $0.14 per share in the prior reporting period.
One of the key indicators of Avantor Inc's financial health, its revenue, also depreciated by 5.645% to $1.68 billion from $1.78 billion in the corresponding reporting period a year prior. Additionally, the company recorded a sequential decrease in revenue of 2.496% from $1.72 billion. These declines in revenue and profit reflect a challenging operating environment for Avantor Inc during this period.
Avantor Inc

Avantor Inc's Revenue Softens in Latest Financial Report2.



Avantor Inc, a Laboratory Analytical Instruments company, recently released its financial results for the October to December 31, 2023 fiscal period. The numbers highlight a decline in income and revenue compared to the previous year. Additionally, the company reported a decrease in profitability and a decline in inventories. This article will analyze the impact of these financial results on Avantor Inc and its future prospects.
Revenue and Earnings Decline
Avantor Inc's financial report reveals a 4.022% decrease in revenue, amounting to $1.72 billion. Simultaneously, the earnings per share dropped by 22.62% to $0.14. These figures indicate a challenging period for the company, potentially signaling a slump in demand or other operational difficulties.
Avantor Inc

Avantor Inc's EPS Plummets by 36% Amidst Weak Demand, Impacting Investors' Confidence

The stock market is a constantly changing and evolving landscape, with stocks and companies going through ups and downs that can be both thrilling and daunting for investors. One such company that has recently faced challenges is Avantor Inc, a Laboratory Analytical Instruments company.
In the financial span closing September 30, 2023, Avantor Inc experienced a drop in EPS by -36% to $0.16 per share. This decline in earnings can be attributed to a decrease in revenue of -7.342% to $1.72 billion compared to the previous reporting season. While these figures may seem discouraging at first glance, it is important to analyze the situation further.
Avantor Inc

Avantor Inc Hit by $6M Tax Charge as Revenue Dips and Shortfall Amplifies



Avantor Inc, a leading provider of solutions and services to the life sciences and advanced technologies industries, has experienced a mixed bag of financial results recently. While the stock gained over the last five trading days and is trading above its 52-week average, the company's financials for the period closing June 30, 2023, reveal a concerning downward trend. These results highlight potential challenges that Avantor Inc may face going forward. Let us delve into the facts and their potential impact on the company's future.
1. Decreased Revenue and Increased Shortfall:
Avantor Inc witnessed a significant decline in revenue, dropping by 8.72% to $1.74 billion compared to the same period last year. Additionally, the company slipped into a shortfall of $0.01 per share, in contrast to the previous year's bottom line of $0.18 per share. These figures indicate a reduced ability to generate profits, which could hamper the company's financial stability and growth prospects.






Avantor Inc's Segments
Laboratory Solutions    67.87 % of total Revenue
Bioscience Production    32.13 % of total Revenue
Proprietary    53.68 % of total Revenue
Third-party    46.32 % of total Revenue





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com